K

Kiniksa Pharmaceuticals Ltd

D
KNSA
USD
0.985
(3.8964%)
Market Closed
12,091.00
Volume
EPS
-
Div Yield
-175.100000
P/E
1,871,216,095.68
Market Cap
Today
3.8964%
1 Week
7.117%
1 Month
-1.371%
6 Months
33.393%
12 Months
49.743%
Year To Date
50.000%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
T
TGTX
0.05
(0.1981%)
USD
A
ARVN
0.63
(2.522%)
USD
S
SRNE
(%)
USD
O
ORTX
(%)
USD
C
CRVS
0.07
(1.275%)
USD
E
EVLO
(%)
USD
A
APLS
1.07
(3.0014%)
USD

Title:
Kiniksa Pharmaceuticals International plc

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
Do you need help or have a question?
Contact Us